BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25736805)

  • 1. Expression of Kit and Etv1 in restricted brain regions supports a brain-cell progenitor as an origin for cranial germinomas.
    Tan C; Scotting P
    Cancer Genet; 2015 Mar; 208(3):55-61. PubMed ID: 25736805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-kit gene mutation: common and widely distributed in intracranial germinomas.
    Kamakura Y; Hasegawa M; Minamoto T; Yamashita J; Fujisawa H
    J Neurosurg; 2006 Mar; 104(3 Suppl):173-80. PubMed ID: 16572634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas.
    Fukushima S; Otsuka A; Suzuki T; Yanagisawa T; Mishima K; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Narita Y; Shibui S; Kato M; Shibata T; Matsutani M; Nishikawa R; Ichimura K;
    Acta Neuropathol; 2014; 127(6):911-25. PubMed ID: 24452629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways.
    Schulte SL; Waha A; Steiger B; Denkhaus D; Dörner E; Calaminus G; Leuschner I; Pietsch T
    Oncotarget; 2016 Aug; 7(34):55026-55042. PubMed ID: 27391150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.
    Lindsay H; Huang Y; Du Y; Braun FK; Teo WY; Kogiso M; Qi L; Zhang H; Zhao S; Mao H; Lin F; Baxter P; Su JM; Terashima K; Perlaky L; Chintagumpala M; Adesina A; Lau CC; Williams Parsons D; Li XN
    J Neurooncol; 2016 May; 128(1):47-56. PubMed ID: 26956263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-kit gene mutations in intracranial germinomas.
    Sakuma Y; Sakurai S; Oguni S; Satoh M; Hironaka M; Saito K
    Cancer Sci; 2004 Sep; 95(9):716-20. PubMed ID: 15471556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-kit expression in germinoma: an immunohistochemistry-based study.
    Nakamura H; Takeshima H; Makino K; Kuratsu J
    J Neurooncol; 2005 Nov; 75(2):163-7. PubMed ID: 16132509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors.
    Miyanohara O; Takeshima H; Kaji M; Hirano H; Sawamura Y; Kochi M; Kuratsu J
    J Neurosurg; 2002 Jul; 97(1):177-83. PubMed ID: 12134909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOG.
    Santagata S; Hornick JL; Ligon KL
    Am J Surg Pathol; 2006 Dec; 30(12):1613-8. PubMed ID: 17122519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers.
    Hoei-Hansen CE; Sehested A; Juhler M; Lau YF; Skakkebaek NE; Laursen H; Rajpert-de Meyts E
    J Pathol; 2006 May; 209(1):25-33. PubMed ID: 16456896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The embryonic stem cell factor UTF1 serves as a reliable diagnostic marker for germinomas.
    Pantazis G; Harter PN; Capper D; Kohlhof P; Mittelbronn M; Schittenhelm J
    Pathology; 2014 Apr; 46(3):225-9. PubMed ID: 24614704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary extragonadal germinoma of the medulla oblongata.
    Nakatsuka S; Tateishi A; Nagano T; Kimura H; Nakajo K; Takahashi J; Taki T
    Int J Surg Pathol; 2012 Jun; 20(3):276-9. PubMed ID: 22142637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological features of intracranial germinomas with reference to fibrous tissue and granulomatous change.
    Utsuki S; Oka H; Tanizaki Y; Kondo K; Kawano N; Fujii K
    Brain Tumor Pathol; 2005; 22(1):9-13. PubMed ID: 18095098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma.
    Takeshima H; Kuratsu J
    Surg Neurol; 2003 Oct; 60(4):321-4; discussion 324-5. PubMed ID: 14505850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and distribution of c-kit receptor and its ligand in human CNS germ cell tumors: a useful histological marker for the diagnosis of germinoma.
    Takeshima H; Kaji M; Uchida H; Hirano H; Kuratsu J
    Brain Tumor Pathol; 2004; 21(1):13-6. PubMed ID: 15696963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging characteristics of primary central nervous system germinoma with histopathologic correlation: a retrospective study.
    Douglas-Akinwande AC; Ying J; Momin Z; Mourad A; Hattab EM
    Acad Radiol; 2009 Nov; 16(11):1356-65. PubMed ID: 19643635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of intracranial germinoma showing a cell arrangement mimicking carcinoma.
    Ohta Y; Suzuki T; Tonoike T; Hamatani S; Ohike N; Shiokawa A; Kushima M; Ota H
    Diagn Cytopathol; 2010 Feb; 38(2):132-6. PubMed ID: 20073098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.
    Nakai Y; Nonomura N; Oka D; Shiba M; Arai Y; Nakayama M; Inoue H; Nishimura K; Aozasa K; Mizutani Y; Miki T; Okuyama A
    Biochem Biophys Res Commun; 2005 Nov; 337(1):289-96. PubMed ID: 16188233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
    Looijenga LH; de Leeuw H; van Oorschot M; van Gurp RJ; Stoop H; Gillis AJ; de Gouveia Brazao CA; Weber RF; Kirkels WJ; van Dijk T; von Lindern M; Valk P; Lajos G; Olah E; Nesland JM; Fosså SD; Oosterhuis JW
    Cancer Res; 2003 Nov; 63(22):7674-8. PubMed ID: 14633689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.